Physician profile
Joel Hershey
NPI 1760425649
$1,466.10
in general payments reported to CMS, 2019-2025
17 companies · $444 in 2025
The $444 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $45.20 · 2021: $251 · 2022: $110 · 2023: $242 · 2024: $260 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $358.32 | 2021-2025 | |
| Glaxosmithkline, LLC. | $177.20 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Merck Sharp & Dohme LLC | $168.11 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Alkermes, INC. | $149.70 | 2025 | Aristada, Lybalvi |
| Cranial Technologies, INC | $141.74 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $103.11 | 2019-2024 | |
| Seqirus USA INC | $79.72 | 2022-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Boston Scientific Corporation | $61.84 | 2021-2023 | |
| Novo Nordisk INC | $37.98 | 2024-2025 | Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $32.01 | 2020 | |
| Amarin Pharma, INC. | $28.80 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $24.62 | 2022 | |
| Gilead Sciences, INC. | $24.20 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $22.68 | 2023 | Rexulti |
| Lundbeck LLC | $21.10 | 2025 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $20.16 | 2025 | |
| Qiagen, LLC | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Hershey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.